Bortezomib (Velcade) treatment of AL amyloidosis: Indiana University experience

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Primary treatment of AL amyloidosis is to target the plasma cell clone which produces the immunoglobulin light chain precursor of amyloid fibrils. A number of chemotherapeutic regimens have been used and all have shown varying response in individual patients. Most recently, bortezomib (Velcade) has been used with consistent success as not only a primary but also a secondary line therapy for patients with either multiple-myeloma or AL amyloidosis. Here, we report the experience with use of bortezomib for AL amyloidosis at Indiana University Medical Center.

Original languageEnglish (US)
Number of pages1
JournalAmyloid
Volume18
Issue numberSUPPL. 1
DOIs
StatePublished - Jun 2011

Fingerprint

Amyloidosis
Immunoglobulin Light Chains
Plasma Cells
Multiple Myeloma
Amyloid
Therapeutics
Clone Cells
Bortezomib

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Bortezomib (Velcade) treatment of AL amyloidosis : Indiana University experience. / Abonour, R.; Kramer, G.; Suvannasankha, A.; Benson, M. D.

In: Amyloid, Vol. 18, No. SUPPL. 1, 06.2011.

Research output: Contribution to journalArticle

@article{6433b4abd7e54bdab4eb129c3b12700d,
title = "Bortezomib (Velcade) treatment of AL amyloidosis: Indiana University experience",
abstract = "Primary treatment of AL amyloidosis is to target the plasma cell clone which produces the immunoglobulin light chain precursor of amyloid fibrils. A number of chemotherapeutic regimens have been used and all have shown varying response in individual patients. Most recently, bortezomib (Velcade) has been used with consistent success as not only a primary but also a secondary line therapy for patients with either multiple-myeloma or AL amyloidosis. Here, we report the experience with use of bortezomib for AL amyloidosis at Indiana University Medical Center.",
author = "R. Abonour and G. Kramer and A. Suvannasankha and Benson, {M. D.}",
year = "2011",
month = "6",
doi = "10.3109/13506129.2011.574354",
language = "English (US)",
volume = "18",
journal = "Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis",
issn = "1350-6129",
publisher = "Informa Healthcare",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Bortezomib (Velcade) treatment of AL amyloidosis

T2 - Indiana University experience

AU - Abonour, R.

AU - Kramer, G.

AU - Suvannasankha, A.

AU - Benson, M. D.

PY - 2011/6

Y1 - 2011/6

N2 - Primary treatment of AL amyloidosis is to target the plasma cell clone which produces the immunoglobulin light chain precursor of amyloid fibrils. A number of chemotherapeutic regimens have been used and all have shown varying response in individual patients. Most recently, bortezomib (Velcade) has been used with consistent success as not only a primary but also a secondary line therapy for patients with either multiple-myeloma or AL amyloidosis. Here, we report the experience with use of bortezomib for AL amyloidosis at Indiana University Medical Center.

AB - Primary treatment of AL amyloidosis is to target the plasma cell clone which produces the immunoglobulin light chain precursor of amyloid fibrils. A number of chemotherapeutic regimens have been used and all have shown varying response in individual patients. Most recently, bortezomib (Velcade) has been used with consistent success as not only a primary but also a secondary line therapy for patients with either multiple-myeloma or AL amyloidosis. Here, we report the experience with use of bortezomib for AL amyloidosis at Indiana University Medical Center.

UR - http://www.scopus.com/inward/record.url?scp=79959968804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959968804&partnerID=8YFLogxK

U2 - 10.3109/13506129.2011.574354

DO - 10.3109/13506129.2011.574354

M3 - Article

C2 - 21838468

AN - SCOPUS:79959968804

VL - 18

JO - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

JF - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

SN - 1350-6129

IS - SUPPL. 1

ER -